Several inhibitors of ornithine and adenosylmethionine decarboxylases may also have antiproliferative effects unrelated to polyamine depletion.
D012437:Adenosylmethionine Decarboxylase / Q000037:antagonists & inhibitors*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D003959:Diamines / Q000494:pharmacology; D000518:Eflornithine; D006801:Humans; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000166:cytology*; D009952:Ornithine / Q000031:analogs & derivatives / Q000494:pharmacology; D065108:Ornithine Decarboxylase Inhibitors; D010835:Phytohemagglutinins / Q000494:pharmacology; D011073:Polyamines / Q000378:metabolism*
D003959:Diamines; D065108:Ornithine Decarboxylase Inhibitors; D010835:Phytohemagglutinins; D011073:Polyamines; D004247:DNA; D009952:Ornithine; D002262:Carboxy-Lyases; D012437:Adenosylmethionine Decarboxylase; D000518:Eflornithine